AIRA Matrix vs Indica Labs (2026)

AI Health Index verifiedNovember 16, 2026
Verdict

AIRA Matrix and Indica Labs both sell AI for pathology to laboratories and drug developers, and they sit at different points on the path to clinical use. Indica's HALO AP Dx is an enterprise digital pathology platform cleared by the FDA for primary diagnosis on named scanners, building cases from LIS data and sending the finished report back. On it run Indica's Breast IHC, Lung PD-L1 and Prostate AI and third party AI such as Lunit's, CE IVDR marked in Europe and research use only in the United States, and the HALO research software serves pharma and research institutes. NeoGenomics, the National Cancer Institute and Nottingham University Hospitals are named users. AIRA Matrix, based in Thane, India, labels its products Research Use Only. AIRATox triages and quantifies findings in toxicology studies on a self supervised model trained on 130,000 whole slide images across six species, PredTox predicts organ toxicity from compound data, and AIRADHI manages GLP studies. AIRAProstate classifies Gleason patterns on prostate biopsies and prostatectomies, and AIRAQc flags slides with artifacts against thresholds a lab sets. Peer reviewed studies with Johns Hopkins, Radboud University Medical Center and LabCorp cover its models. A laboratory moving to digital primary diagnosis in the United States has a cleared platform in Indica's HALO AP Dx; a toxicology group or drug developer looking for preclinical triage and compound screening has tools built for that in AIRA Matrix. Indica runs its cloud service on AWS inside an account the customer controls, and AIRA Matrix offers cloud or on premise deployment. Neither publishes a price or a security attestation such as SOC 2 or ISO 27001.

The case for AIRA Matrix
  • AIRATox screens, triages and quantifies findings in toxicology studies across species, on a model trained on 130,000 whole slide images from more than 40 labs.
  • PredTox predicts in vivo organ toxicity from compound data on a desktop platform, keeping molecule information inside the organization.
  • AIRADHI manages GLP studies with audit trails and electronic signatures for 21 CFR Part 11, in the cloud or on premise.
  • AIRAQc accepts or flags each slide for rescanning against artifact thresholds the lab sets, with 95% sensitivity and 96% specificity reported.
  • Prostate cancer models studied with Johns Hopkins and in a Radboud evaluation of Gleason algorithms on outside data.
The case for Indica Labs
  • HALO AP Dx is FDA 510(k) cleared for primary diagnosis with the Hamamatsu NanoZoomer S360MD and the Leica Aperio GT 450 DX.
  • Breast IHC, Lung PD-L1 and Prostate AI run beside third party AI such as Lunit's, CE IVDR marked in Europe, the UK and Switzerland.
  • Cases are built from LIS data, and the finished pathology report is sent back to the LIS automatically.
  • Cloud Services run HALO on AWS inside an account the customer controls, and NeoGenomics is moving its digital pathology infrastructure onto it.
  • HALO research software serves pharma and research institutes for tissue image analysis.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AIRA Matrix and Indica Labs are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact AIRA Matrix Indica Labs
Primary category Digital Pathology AI Digital Pathology AI
Founded Not recorded 2007
Headquarters Thane, Maharashtra, India Albuquerque, New Mexico, United States
Website airamatrix.com indicalab.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
A
AIRA Matrix
I
Indica Labs
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Change Log

Product updates

The latest logged changes from each vendor, newest first, each linked to its source.

Indica Labs

  • Clinical evidence

    Indica Labs published a case study on Source BioScience, which reports histopathology for more than 90 NHS trusts on Indica's HALO AP platform.

    Source
  • EHR / interoperability

    A Voicebrook VoiceOver PRO integration with the HALO AP platform is now available, adding voice control of case and slide navigation (zoom, pan, annotation, tab switching) and voice ordering of stains and AI analyses.

    Source
  • Product / capability

    Indica Labs announced version 4.3 of its HALO, HALO AI, and HALO Link platforms.

    Source
All 3 Indica Labs updates →
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached.

AIRA Matrix

AIRA Matrix, based in Thane, India, sells deep learning pathology tools labeled Research Use Only: AIRATox, PredTox and AIRADHI for preclinical toxicology and drug development, AIRAProstate for prostate cancer analysis and AIRAQc for slide quality control, in the cloud or on premise. Its algorithms are offered through Sectra, Techcyte, Gestalt and Lumea, and peer reviewed studies with Johns Hopkins, Radboud University Medical Center and LabCorp cover its models. No security attestation, HIPAA position or price is published.

Source: AI Health Index, November 2026

Indica Labs

Indica Labs sells HALO AP Dx, an enterprise digital pathology platform FDA cleared for primary diagnosis, with its own Breast IHC, Lung PD-L1 and Prostate AI and third party AI, CE IVDR marked in Europe and research use only in the US, plus HALO research software for pharma. It builds cases from LIS data and returns reports to the LIS, runs a cloud service on AWS in the customer's own account, and names NeoGenomics and the National Cancer Institute among users. No price or security attestation is published.

Source: AI Health Index, November 2026

FAQ

Questions buyers ask

How does AIRA Matrix compare with Indica Labs?

Both sell AI image analysis for pathology. Indica Labs sells HALO AP Dx, a digital pathology platform cleared by the FDA for primary diagnosis, with its own and third party AI, plus HALO research software. AIRA Matrix labels its products Research Use Only and concentrates on preclinical toxicology and drug development, alongside prostate cancer analysis and slide quality control. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

How much do AIRA Matrix and Indica Labs cost?

Neither publishes a price. AIRA Matrix offers image analysis as a service, pay per use for small projects or by subscription, beside its software. Indica Labs sells HALO software for installation by the laboratory or as a managed cloud service on AWS. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Are AIRA Matrix or Indica Labs FDA cleared?

Indica Labs' HALO AP Dx is FDA 510(k) cleared for primary diagnosis with named scanners and displays (K232833 and K252762); its AI applications are research use only in the United States. AIRA Matrix has no FDA clearance and labels its products Research Use Only. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Which systems do AIRA Matrix and Indica Labs work with?

Indica's HALO AP Dx builds cases from LIS or LIMS data, sends reports back to the LIS, is DICOM compliant and runs on AWS under its Cloud Services. AIRA Matrix algorithms are offered through Sectra's Amplifier marketplace, Techcyte Fusion, Gestalt PathFlow and Lumea, follow HL7 metadata standards and work with multiple scanners. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Do AIRA Matrix and Indica Labs support preclinical research?

Both do. Indica's HALO research software is used by pharma and research institutes for tissue image analysis. AIRA Matrix sells AIRATox for toxicology study slides across species, PredTox for toxicity prediction from compound data, and AIRADHI for GLP image management with 21 CFR Part 11 controls. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified November 16, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.

Disclosure

Neither AIRA Matrix nor Indica Labs publishes a price, a security attestation such as SOC 2 or ISO 27001, or results for its AI by site, scanner or patient group.

AIRA Matrix labels every product Research Use Only while its prostate pages describe diagnosis and treatment planning, states no HIPAA position and names no host for its cloud deployment.

Indica's FDA clearance covers the HALO AP Dx viewing platform for primary diagnosis, not its AI, which is research use only in the United States. It claims built in HIPAA compliance without a business associate position or service privacy document, and publishes little on how its AI performs.